Interestingly, our study showed no significant difference in sex between the RNF213 p.R4810K variant carriers and noncarriers among patients with IS, although research has shown that female carriers are generally 2 times more likely to develop MMD than male carriers.34 This evidence concerns the gene RNF213 and multiminicore myopathy.